Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer

Overview of attention for article published in Frontiers in Nuclear Medicine, September 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age

Mentioned by

twitter: 3 X users

Readers on

mendeley: 1 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,727 followers.

RT @FrontNuclearMed: New Research: Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand the…

14 Sep 2023

Reply Repost Favourite

RT @FrontNuclearMed: New Research: Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand the…

14 Sep 2023

Reply Repost Favourite

New Research: Multicentric 68Ga-PSMA PET radiomics for treatment response assessment of 177Lu-PSMA-617 radioligand therapy in patients with metastatic castration-resistant prostate cancer #NuclearMedicine https://t.co/aAFVCi7Tjo

14 Sep 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.